Skip to main content
OpenTrials
Completed

NCT Number: NCT03723499

Endoscopic Treatment of Bronchial Carcinoid Tumors

Carcinoid tumors of the lung are considered to be a low-grade malignancy. Surgical resection is considered the standard approach. Recent data has shown that a complete endoscopic treatment could be considered. An endoscopic treatment is can be a alternative to invasive surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Carcinoid Tumor Adenocarcinoma Carcinoma Disease Attributes Neoplasms Neoplasms by Histologic Type Neoplasms, Germ Cell and Embryonal Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Neuroectodermal Tumors Neuroendocrine Tumors Pathologic Processes Pathological Conditions, Signs and Symptoms Recurrence

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Saint-Etienne

Saint-Etienne, 42055, France

About this study

The objective of this study is to evaluate the feasibility and therapeutic method of endoscopic treatment of bronchial carcinoid tumors.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients treated by endoscopic approach for a carcinoid tumor at the University Hospital Centre of Saint-Etienne between November 1995 to December 2017.

Exclusion criteria

  • Patients treated for a recurrence of carcinoid tumor.
  • Patients with metastatic disease.

Treatment and study plan

medical data collection

Other

Medical data collection by medical record will be collected: demographics data, medical history, clinical symptoms, smoking, type of endoscopic method, complete treatment or not, type of surgeries if yes, anatomopathology of the injury and recurrence if yes

Primary outcomes

  1. Complete endoscopic treatment

    Time frame: Month 1

    patients who have a complete endoscopic treatment

Secondary outcomes

  1. Type of endoscopic method used

    Time frame: Month 1

    Analysis type of endoscopic method used.

  2. Tumor localization

    Time frame: Month 1

    Analysis the tumor localization.

  3. Deadline before recurrence

    Time frame: 10 years

    Analysis the deadline before recurrence of the tumor.

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Official study title

Feasibility and Therapeutic Method of Endoscopic Treatment of Bronchial Carcinoid Tumors: 22 Years Experience of Saint-Etienne

Important dates

Study start
1995
Primary completion
2017
Study completion
2017
First posted
Oct 29, 2018
Registry last updated
Oct 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.